Straits Times Index
3,332.80 -10.55 (-0.32%) S&P 500
5,460.48 -22.39 (-0.41%) Dow
39,118.86 -45.24 (-0.12%) Nasdaq
17,732.60 -126.10 (-0.71%) Bitcoin USD
61,863.47 +920.83 (+1.51%) CMC Crypto 200
1,285.19 +1.36 (+0.11%)
Abacus Life, Inc. (ABL)
| Previous close | 9.10 |
| Open | 9.11 |
| Bid | 8.65 x 100 |
| Ask | 9.09 x 100 |
| Day's range | 8.65 - 9.40 |
| 52-week range | 5.47 - 13.25 |
| Volume | |
| Avg. volume | 56,396 |
| Market cap | 652.942M |
| Beta (5Y monthly) | 0.17 |
| PE ratio (TTM) | ∞ |
| EPS (TTM) | 0.00 |
| Earnings date | 14 Aug 2024 - 18 Aug 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 13.50 |
GlobeNewswireAbacus Life Announces Closing of Public Offering of 11,500,000 Shares of Common Stock
ORLANDO, Fla., June 24, 2024 (GLOBE NEWSWIRE) -- Abacus Life, Inc. (“Abacus” or the “Company”) (NASDAQ: ABL), a pioneering alternative asset manager specializing in longevity and actuarial technology, today announced the closing of its oversubscribed underwritten public offering of 11,500,000 shares of its common stock, including the exercise in full by the underwriters of their option to purchase an additional 1,500,000 shares of common stock, at the public offering price of $8.00 per share. Th
- GlobeNewswire
Abacus Life Announces Pricing of Public Offering of Common Stock
ORLANDO, Fla., June 20, 2024 (GLOBE NEWSWIRE) -- Abacus Life, Inc. (“Abacus” or the “Company”) (NASDAQ: ABL), a pioneering alternative asset manager specializing in longevity and actuarial technology, today announced the pricing of its oversubscribed underwritten public offering of 10,000,000 shares of its common stock at a price to the public of $8.00 per share. In connection with the offering, the Company also granted the underwriters a 30-day option to purchase up to an additional 1,500,000 s
- GlobeNewswire
Abacus Life Announces Proposed Public Offering of Common Stock
ORLANDO, Fla., June 13, 2024 (GLOBE NEWSWIRE) -- Abacus Life, Inc. (“Abacus” or the “Company”) (NASDAQ: ABL), a pioneering alternative asset manager specializing in longevity and actuarial technology, today announced that it has commenced an underwritten public offering of 10,000,000 shares of its common stock. In connection with the offering, Abacus intends to grant the underwriters a 30-day option to purchase up to an additional 1,500,000 shares of common stock at the public offering price. Al
